Enjoy complimentary customisation on priority with our Enterprise License!
The lung cancer therapeutics market size is forecast to increase by USD 10.53 billion at a CAGR of 7.69% between 2023 and 2028. The market is experiencing significant growth, driven by the increasing adoption of precision medicine and research and development (RD) initiatives. The market is witnessing a heavy contribution from immunomodulators, a type of molecule, as part of the drug class, which is gaining popularity due to their targeted approach in treating lung cancer. Regenerative therapies, another emerging trend, are expected to revolutionize the treatment landscape, offering novel treatment options for patients. The therapy types, including targeted therapy, chemotherapy, and immunotherapy, continue to dominate the market. Astellas Pharma and other key players are investing heavily in RD to bring new drug classes and treatment types to the market.
The market is expected to grow steadily, offering significant opportunities for stakeholders.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Therapy
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.